Satoh Takeshi, Manel Nicolas
Institut Curie, INSERM U932, Paris, France.
Methods Mol Biol. 2013;960:401-409. doi: 10.1007/978-1-62703-218-6_30.
Monocyte-derived dendritic cells (MDDCs) are widely used in the field of human immunology. Although a variety of gene delivery procedures have been used in MDDC, it has remained difficult to achieve robust gene transductions. In this chapter, we describe a procedure for high efficiency gene transduction in human MDDCs using lentiviral vectors. Gene transduction based on HIV-1-derived lentiviral vectors is restricted at the level of reverse transcription by the cellular protein SAMHD1 in MDDCs. Co-transduction of the MDDCs with helper particles derived from SIVmac that contain the viral protein Vpx removes this restriction, leading to a drastic increase in the rate of gene transduction. This procedure leads to nontoxic, efficient and stable transduction in MDDCs. It can be applied to any HIV-1-derived lentiviral vector, including shRNA lentiviral vectors for RNAi. Transduced MDDCs are not activated by the transduction and can be activated normally by TLR ligands.
单核细胞衍生的树突状细胞(MDDC)在人类免疫学领域中被广泛应用。尽管已经在MDDC中使用了多种基因递送方法,但实现高效的基因转导仍然困难。在本章中,我们描述了一种使用慢病毒载体在人MDDC中进行高效基因转导的方法。基于HIV-1衍生的慢病毒载体的基因转导在MDDC中受到细胞蛋白SAMHD1在逆转录水平的限制。将MDDC与源自SIVmac且包含病毒蛋白Vpx的辅助颗粒共转导可消除此限制,从而导致基因转导速率急剧增加。该方法可在MDDC中实现无毒、高效且稳定的转导。它可应用于任何HIV-1衍生的慢病毒载体,包括用于RNA干扰的shRNA慢病毒载体。转导的MDDC不会因转导而被激活,并且可以被TLR配体正常激活。